1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global PD-1 and PD-L1 Antibody Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 PD-1 inhibitor 1.2.3 PD-L1 inhibitor 1.3 Market by Application 1.3.1 Global PD-1 and PD-L1 Antibody Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Solid Tumors 1.3.3 Blood-related Tumors 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global PD-1 and PD-L1 Antibody Market Perspective (2016-2027) 2.2 PD-1 and PD-L1 Antibody Growth Trends by Regions 2.2.1 PD-1 and PD-L1 Antibody Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 PD-1 and PD-L1 Antibody Historic Market Share by Regions (2016-2021) 2.2.3 PD-1 and PD-L1 Antibody Forecasted Market Size by Regions (2022-2027) 2.3 PD-1 and PD-L1 Antibody Industry Dynamic 2.3.1 PD-1 and PD-L1 Antibody Market Trends 2.3.2 PD-1 and PD-L1 Antibody Market Drivers 2.3.3 PD-1 and PD-L1 Antibody Market Challenges 2.3.4 PD-1 and PD-L1 Antibody Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top PD-1 and PD-L1 Antibody Players by Revenue 3.1.1 Global Top PD-1 and PD-L1 Antibody Players by Revenue (2016-2021) 3.1.2 Global PD-1 and PD-L1 Antibody Revenue Market Share by Players (2016-2021) 3.2 Global PD-1 and PD-L1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by PD-1 and PD-L1 Antibody Revenue 3.4 Global PD-1 and PD-L1 Antibody Market Concentration Ratio 3.4.1 Global PD-1 and PD-L1 Antibody Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by PD-1 and PD-L1 Antibody Revenue in 2020 3.5 PD-1 and PD-L1 Antibody Key Players Head office and Area Served 3.6 Key Players PD-1 and PD-L1 Antibody Product Solution and Service 3.7 Date of Enter into PD-1 and PD-L1 Antibody Market 3.8 Mergers & Acquisitions, Expansion Plans 4 PD-1 and PD-L1 Antibody Breakdown Data by Type 4.1 Global PD-1 and PD-L1 Antibody Historic Market Size by Type (2016-2021) 4.2 Global PD-1 and PD-L1 Antibody Forecasted Market Size by Type (2022-2027) 5 PD-1 and PD-L1 Antibody Breakdown Data by Application 5.1 Global PD-1 and PD-L1 Antibody Historic Market Size by Application (2016-2021) 5.2 Global PD-1 and PD-L1 Antibody Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America PD-1 and PD-L1 Antibody Market Size (2016-2027) 6.2 North America PD-1 and PD-L1 Antibody Market Size by Type 6.2.1 North America PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) 6.2.2 North America PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) 6.2.3 North America PD-1 and PD-L1 Antibody Market Size by Type (2016-2027) 6.3 North America PD-1 and PD-L1 Antibody Market Size by Application 6.3.1 North America PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) 6.3.2 North America PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) 6.3.3 North America PD-1 and PD-L1 Antibody Market Size by Application (2016-2027) 6.4 North America PD-1 and PD-L1 Antibody Market Size by Country 6.4.1 North America PD-1 and PD-L1 Antibody Market Size by Country (2016-2021) 6.4.2 North America PD-1 and PD-L1 Antibody Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe PD-1 and PD-L1 Antibody Market Size (2016-2027) 7.2 Europe PD-1 and PD-L1 Antibody Market Size by Type 7.2.1 Europe PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) 7.2.2 Europe PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) 7.2.3 Europe PD-1 and PD-L1 Antibody Market Size by Type (2016-2027) 7.3 Europe PD-1 and PD-L1 Antibody Market Size by Application 7.3.1 Europe PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) 7.3.2 Europe PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) 7.3.3 Europe PD-1 and PD-L1 Antibody Market Size by Application (2016-2027) 7.4 Europe PD-1 and PD-L1 Antibody Market Size by Country 7.4.1 Europe PD-1 and PD-L1 Antibody Market Size by Country (2016-2021) 7.4.2 Europe PD-1 and PD-L1 Antibody Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific PD-1 and PD-L1 Antibody Market Size (2016-2027) 8.2 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type 8.2.1 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) 8.2.2 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) 8.2.3 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type (2016-2027) 8.3 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application 8.3.1 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) 8.3.2 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) 8.3.3 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application (2016-2027) 8.4 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region 8.4.1 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region (2016-2021) 8.4.2 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America PD-1 and PD-L1 Antibody Market Size (2016-2027) 9.2 Latin America PD-1 and PD-L1 Antibody Market Size by Type 9.2.1 Latin America PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) 9.2.2 Latin America PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) 9.2.3 Latin America PD-1 and PD-L1 Antibody Market Size by Type (2016-2027) 9.3 Latin America PD-1 and PD-L1 Antibody Market Size by Application 9.3.1 Latin America PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) 9.3.2 Latin America PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) 9.3.3 Latin America PD-1 and PD-L1 Antibody Market Size by Application (2016-2027) 9.4 Latin America PD-1 and PD-L1 Antibody Market Size by Country 9.4.1 Latin America PD-1 and PD-L1 Antibody Market Size by Country (2016-2021) 9.4.2 Latin America PD-1 and PD-L1 Antibody Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa PD-1 and PD-L1 Antibody Market Size (2016-2027) 10.2 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type 10.2.1 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) 10.2.2 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) 10.2.3 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type (2016-2027) 10.3 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application 10.3.1 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) 10.3.2 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) 10.3.3 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application (2016-2027) 10.4 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country 10.4.1 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country (2016-2021) 10.4.2 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AstraZeneca 11.1.1 AstraZeneca Company Details 11.1.2 AstraZeneca Business Overview 11.1.3 AstraZeneca PD-1 and PD-L1 Antibody Introduction 11.1.4 AstraZeneca Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) 11.1.5 AstraZeneca Recent Development 11.2 Bristol-Myers Squibb 11.2.1 Bristol-Myers Squibb Company Details 11.2.2 Bristol-Myers Squibb Business Overview 11.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Antibody Introduction 11.2.4 Bristol-Myers Squibb Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) 11.2.5 Bristol-Myers Squibb Recent Development 11.3 F. Hoffmann-La Roche 11.3.1 F. Hoffmann-La Roche Company Details 11.3.2 F. Hoffmann-La Roche Business Overview 11.3.3 F. Hoffmann-La Roche PD-1 and PD-L1 Antibody Introduction 11.3.4 F. Hoffmann-La Roche Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) 11.3.5 F. Hoffmann-La Roche Recent Development 11.4 Merck 11.4.1 Merck Company Details 11.4.2 Merck Business Overview 11.4.3 Merck PD-1 and PD-L1 Antibody Introduction 11.4.4 Merck Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) 11.4.5 Merck Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Details 11.5.2 Pfizer Business Overview 11.5.3 Pfizer PD-1 and PD-L1 Antibody Introduction 11.5.4 Pfizer Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) 11.5.5 Pfizer Recent Development 11.6 Roche 11.6.1 Roche Company Details 11.6.2 Roche Business Overview 11.6.3 Roche PD-1 and PD-L1 Antibody Introduction 11.6.4 Roche Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) 11.6.5 Roche Recent Development 11.7 Novartis 11.7.1 Novartis Company Details 11.7.2 Novartis Business Overview 11.7.3 Novartis PD-1 and PD-L1 Antibody Introduction 11.7.4 Novartis Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) 11.7.5 Novartis Recent Development 11.8 Jiangsu HengRui Medicine 11.8.1 Jiangsu HengRui Medicine Company Details 11.8.2 Jiangsu HengRui Medicine Business Overview 11.8.3 Jiangsu HengRui Medicine PD-1 and PD-L1 Antibody Introduction 11.8.4 Jiangsu HengRui Medicine Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) 11.8.5 Jiangsu HengRui Medicine Recent Development 11.9 Innovent 11.9.1 Innovent Company Details 11.9.2 Innovent Business Overview 11.9.3 Innovent PD-1 and PD-L1 Antibody Introduction 11.9.4 Innovent Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) 11.9.5 Innovent Recent Development 11.10 Eli Lilly 11.10.1 Eli Lilly Company Details 11.10.2 Eli Lilly Business Overview 11.10.3 Eli Lilly PD-1 and PD-L1 Antibody Introduction 11.10.4 Eli Lilly Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) 11.10.5 Eli Lilly Recent Development 11.11 GlaxoSmithKline 11.11.1 GlaxoSmithKline Company Details 11.11.2 GlaxoSmithKline Business Overview 11.11.3 GlaxoSmithKline PD-1 and PD-L1 Antibody Introduction 11.11.4 GlaxoSmithKline Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) 11.11.5 GlaxoSmithKline Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global PD-1 and PD-L1 Antibody Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of PD-1 inhibitor Table 3. Key Players of PD-L1 inhibitor Table 4. Global PD-1 and PD-L1 Antibody Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global PD-1 and PD-L1 Antibody Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global PD-1 and PD-L1 Antibody Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global PD-1 and PD-L1 Antibody Market Share by Regions (2016-2021) Table 8. Global PD-1 and PD-L1 Antibody Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global PD-1 and PD-L1 Antibody Market Share by Regions (2022-2027) Table 10. PD-1 and PD-L1 Antibody Market Trends Table 11. PD-1 and PD-L1 Antibody Market Drivers Table 12. PD-1 and PD-L1 Antibody Market Challenges Table 13. PD-1 and PD-L1 Antibody Market Restraints Table 14. Global PD-1 and PD-L1 Antibody Revenue by Players (2016-2021) & (US$ Million) Table 15. Global PD-1 and PD-L1 Antibody Market Share by Players (2016-2021) Table 16. Global Top PD-1 and PD-L1 Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Antibody as of 2020) Table 17. Ranking of Global Top PD-1 and PD-L1 Antibody Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by PD-1 and PD-L1 Antibody Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players PD-1 and PD-L1 Antibody Product Solution and Service Table 21. Date of Enter into PD-1 and PD-L1 Antibody Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million) Table 24. Global PD-1 and PD-L1 Antibody Revenue Market Share by Type (2016-2021) Table 25. Global PD-1 and PD-L1 Antibody Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global PD-1 and PD-L1 Antibody Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global PD-1 and PD-L1 Antibody Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global PD-1 and PD-L1 Antibody Revenue Market Share by Application (2016-2021) Table 29. Global PD-1 and PD-L1 Antibody Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global PD-1 and PD-L1 Antibody Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million) Table 32. North America PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) & (US$ Million) Table 33. North America PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) (US$ Million) Table 34. North America PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) & (US$ Million) Table 35. North America PD-1 and PD-L1 Antibody Market Size by Country (2016-2021) & (US$ Million) Table 36. North America PD-1 and PD-L1 Antibody Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million) Table 38. Europe PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) (US$ Million) Table 40. Europe PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe PD-1 and PD-L1 Antibody Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe PD-1 and PD-L1 Antibody Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America PD-1 and PD-L1 Antibody Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America PD-1 and PD-L1 Antibody Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country (2022-2027) & (US$ Million) Table 61. AstraZeneca Company Details Table 62. AstraZeneca Business Overview Table 63. AstraZeneca PD-1 and PD-L1 Antibody Product Table 64. AstraZeneca Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million) Table 65. AstraZeneca Recent Development Table 66. Bristol-Myers Squibb Company Details Table 67. Bristol-Myers Squibb Business Overview Table 68. Bristol-Myers Squibb PD-1 and PD-L1 Antibody Product Table 69. Bristol-Myers Squibb Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million) Table 70. Bristol-Myers Squibb Recent Development Table 71. F. Hoffmann-La Roche Company Details Table 72. F. Hoffmann-La Roche Business Overview Table 73. F. Hoffmann-La Roche PD-1 and PD-L1 Antibody Product Table 74. F. Hoffmann-La Roche Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million) Table 75. F. Hoffmann-La Roche Recent Development Table 76. Merck Company Details Table 77. Merck Business Overview Table 78. Merck PD-1 and PD-L1 Antibody Product Table 79. Merck Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million) Table 80. Merck Recent Development Table 81. Pfizer Company Details Table 82. Pfizer Business Overview Table 83. Pfizer PD-1 and PD-L1 Antibody Product Table 84. Pfizer Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million) Table 85. Pfizer Recent Development Table 86. Roche Company Details Table 87. Roche Business Overview Table 88. Roche PD-1 and PD-L1 Antibody Product Table 89. Roche Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million) Table 90. Roche Recent Development Table 91. Novartis Company Details Table 92. Novartis Business Overview Table 93. Novartis PD-1 and PD-L1 Antibody Product Table 94. Novartis Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million) Table 95. Novartis Recent Development Table 96. Jiangsu HengRui Medicine Company Details Table 97. Jiangsu HengRui Medicine Business Overview Table 98. Jiangsu HengRui Medicine Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million) Table 99. Jiangsu HengRui Medicine Recent Development Table 100. Innovent Company Details Table 101. Innovent Business Overview Table 102. Innovent PD-1 and PD-L1 Antibody Product Table 103. Innovent Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million) Table 104. Innovent Recent Development Table 105. Eli Lilly Company Details Table 106. Eli Lilly Business Overview Table 107. Eli Lilly PD-1 and PD-L1 Antibody Product Table 108. Eli Lilly Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million) Table 109. Eli Lilly Recent Development Table 110. GlaxoSmithKline Company Details Table 111. GlaxoSmithKline Business Overview Table 112. GlaxoSmithKline PD-1 and PD-L1 Antibody Product Table 113. GlaxoSmithKline Revenue in PD-1 and PD-L1 Antibody Business (2016-2021) & (US$ Million) Table 114. GlaxoSmithKline Recent Development Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Global PD-1 and PD-L1 Antibody Market Share by Type: 2020 VS 2027 Figure 2. PD-1 inhibitor Features Figure 3. PD-L1 inhibitor Features Figure 4. Global PD-1 and PD-L1 Antibody Market Share by Application: 2020 VS 2027 Figure 5. Solid Tumors Case Studies Figure 6. Blood-related Tumors Case Studies Figure 7. PD-1 and PD-L1 Antibody Report Years Considered Figure 8. Global PD-1 and PD-L1 Antibody Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 9. Global PD-1 and PD-L1 Antibody Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global PD-1 and PD-L1 Antibody Market Share by Regions: 2020 VS 2027 Figure 11. Global PD-1 and PD-L1 Antibody Market Share by Regions (2022-2027) Figure 12. Global PD-1 and PD-L1 Antibody Market Share by Players in 2020 Figure 13. Global Top PD-1 and PD-L1 Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Antibody as of 2020 Figure 14. The Top 10 and 5 Players Market Share by PD-1 and PD-L1 Antibody Revenue in 2020 Figure 15. Global PD-1 and PD-L1 Antibody Revenue Market Share by Type (2016-2021) Figure 16. Global PD-1 and PD-L1 Antibody Revenue Market Share by Type (2022-2027) Figure 17. North America PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 18. North America PD-1 and PD-L1 Antibody Market Share by Type (2016-2027) Figure 19. North America PD-1 and PD-L1 Antibody Market Share by Application (2016-2027) Figure 20. North America PD-1 and PD-L1 Antibody Market Share by Country (2016-2027) Figure 21. United States PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. Canada PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Europe PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe PD-1 and PD-L1 Antibody Market Share by Type (2016-2027) Figure 25. Europe PD-1 and PD-L1 Antibody Market Share by Application (2016-2027) Figure 26. Europe PD-1 and PD-L1 Antibody Market Share by Country (2016-2027) Figure 27. Germany PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. France PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. U.K. PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Italy PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Russia PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Nordic PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Asia-Pacific PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific PD-1 and PD-L1 Antibody Market Share by Type (2016-2027) Figure 35. Asia-Pacific PD-1 and PD-L1 Antibody Market Share by Application (2016-2027) Figure 36. Asia-Pacific PD-1 and PD-L1 Antibody Market Share by Region (2016-2027) Figure 37. China PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Japan PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. South Korea PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Southeast Asia PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. India PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Australia PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Latin America PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America PD-1 and PD-L1 Antibody Market Share by Type (2016-2027) Figure 45. Latin America PD-1 and PD-L1 Antibody Market Share by Application (2016-2027) Figure 46. Latin America PD-1 and PD-L1 Antibody Market Share by Country (2016-2027) Figure 47. Mexico PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Brazil PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Middle East & Africa PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa PD-1 and PD-L1 Antibody Market Share by Type (2016-2027) Figure 51. Middle East & Africa PD-1 and PD-L1 Antibody Market Share by Application (2016-2027) Figure 52. Middle East & Africa PD-1 and PD-L1 Antibody Market Share by Country (2016-2027) Figure 53. Turkey PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Saudi Arabia PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. UAE PD-1 and PD-L1 Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. AstraZeneca Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021) Figure 57. Bristol-Myers Squibb Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021) Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021) Figure 59. Merck Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021) Figure 60. Pfizer Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021) Figure 61. Roche Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021) Figure 62. Novartis Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021) Figure 63. Jiangsu HengRui Medicine Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021) Figure 64. Innovent Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021) Figure 65. Eli Lilly Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021) Figure 66. GlaxoSmithKline Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

AstraZeneca Bristol-Myers Squibb F. Hoffmann-La Roche Merck Pfizer Roche Novartis Jiangsu HengRui Medicine Innovent Eli Lilly GlaxoSmithKline